BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36759777)

  • 21. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.
    Neff RT; Jindal RM; Yoo DY; Hurst FP; Agodoa LY; Abbott KC
    Transplantation; 2009 Jul; 88(1):135-41. PubMed ID: 19584693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.
    Azar MM; Cohen E; Ma L; Cissé OH; Gan G; Deng Y; Belfield K; Asch W; Grant M; Gleeson S; Koff A; Gaston DC; Topal J; Curran S; Kulkarni S; Kovacs JA; Malinis M
    Clin Infect Dis; 2022 Mar; 74(4):639-647. PubMed ID: 34017984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin as adjunctive therapy in kidney transplant recipients with severe pneumocystis pneumonia.
    Edey MM; Gunasekera PN; Lobb M; Imran M
    Transpl Infect Dis; 2021 Feb; 23(1):e13454. PubMed ID: 32869412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.
    Eitner F; Hauser IA; Rettkowski O; Rath T; Lopau K; Pliquett RU; Fiedler R; Guba M; Hilgers RD; Floege J; Fischereder M
    Nephrol Dial Transplant; 2011 Jun; 26(6):2013-7. PubMed ID: 21071545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.
    Struijk GH; Gijsen AF; Yong SL; Zwinderman AH; Geerlings SE; Lettinga KD; van Donselaar-van der Pant KA; ten Berge IJ; Bemelman FJ
    Nephrol Dial Transplant; 2011 Oct; 26(10):3391-8. PubMed ID: 21385859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients.
    Ebner L; Walti LN; Rauch A; Furrer H; Cusini A; Meyer AM; Weiler S; Huynh-Do U; Heverhagen J; Arampatzis S; Christe A
    PLoS One; 2016; 11(11):e0164320. PubMed ID: 27824870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study.
    De Castro N; Xu F; Porcher R; Pavie J; Molina JM; Peraldi MN
    Clin Microbiol Infect; 2010 Sep; 16(9):1375-7. PubMed ID: 20041898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population.
    Leth S; Jensen-Fangel S; Østergaard L; Rostved AA; Jespersen B; Søgaard OS
    Scand J Infect Dis; 2014 Oct; 46(10):704-11. PubMed ID: 25131415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
    Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
    Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis carinii pneumonia in renal transplant recipients.
    Branten AJ; Beckers PJ; Tiggeler RG; Hoitsma AJ
    Nephrol Dial Transplant; 1995; 10(7):1194-7. PubMed ID: 7478123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center.
    Arichi N; Kishikawa H; Mitsui Y; Kato T; Nishimura K; Tachikawa R; Tomii K; Shiina H; Igawa M; Ichikawa Y
    Transplant Proc; 2009; 41(1):170-2. PubMed ID: 19249506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Center Retrospective Analysis of Prophylaxis and Treatment of Pneumocystis carinii Pneumonia in Patients with Renal Dysfunction After Renal Transplantation.
    Pan J; Fu Y; Cao Y; Feng G; Zhao J; Shi X; Mo C; Song W; Shen Z
    Ann Transplant; 2020 Nov; 25():e925126. PubMed ID: 33184254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
    Cheng B; Qi C; Zhang S; Wang X
    Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome.
    Bige N; Zafrani L; Lambert J; Peraldi MN; Snanoudj R; Reuter D; Legendre C; Chevret S; Lemiale V; Schlemmer B; Azoulay E; Canet E
    Transpl Infect Dis; 2014 Aug; 16(4):588-96. PubMed ID: 24966154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii.
    Rostved AA; Sassi M; Kurtzhals JA; Sørensen SS; Rasmussen A; Ross C; Gogineni E; Huber C; Kutty G; Kovacs JA; Helweg-Larsen J
    Transplantation; 2013 Nov; 96(9):834-42. PubMed ID: 23903011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab.
    Kim YH; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Park SK; Kim SH; Kwon H; Han DJ
    BMC Nephrol; 2020 Mar; 21(1):93. PubMed ID: 32160881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: Risk factors and implications for infection control.
    Mulpuru S; Knoll G; Weir C; Desjardins M; Johnson D; Gorn I; Fairhead T; Bissonnette J; Bruce N; Toye B; Suh K; Roth V
    Am J Infect Control; 2016 Apr; 44(4):425-31. PubMed ID: 26804301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.
    Choi JS; Lee SH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    PLoS One; 2018; 13(10):e0206231. PubMed ID: 30359436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.